Atlas Trials

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

Clinical trial NCT04221360 · UNKNOWN

Trial details

NCT number
NCT04221360
Sponsor
Chong Kun Dang Pharmaceutical
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Type2 Diabetes Mellitus
Start date
2020-01-29
Primary completion
2020-03-06
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.